The effects of supplements on metabolic parameters in PCOS patients

Read full text
Authors: Malaika Ashraf, Usama Sagheer, Muhammad Umar Rafique
Cited by: 0
References: 3

Abstract

Polycystic ovary syndrome (PCOS) is a highly prevalent medical issue in Pakistan, affecting approximately 52% of women, almost twice the prevalence reported in Western countries.[ [1] Besides being a reproductive disorder, it is also a long-term metabolic disease which has severe health consequences if overlooked. Women with PCOS are at increased risk of developing impaired glucose tolerance, non-alcoholic fatty liver disease, diabetes mellitus type 2, chronic systemic inflammation, high blood pressure, and potential coagulation disorders in the future due to its effect on the body's metabolism.[2] Therefore, it is crucial for physicians to address the diverse aspects of this disease and take measures to improve the deranged metabolic parameters, that contribute to the development of complications. Research suggests that over-the-counter supplementation can be extremely beneficial in this regard. In a triple-blind, randomized clinical trial, women aged 15 to 35 with PCOS were assigned either a magnesium supplement or a placebo to assess serum insulin levels and insulin resistance. Both parameters were measured initially and then compared after 2 and 20 months. The intervention group showed significant reductions in serum insulin levels (P=0.036) and insulin resistance (P=0.032).[3] Another randomized controlled trial involving of sixty women with PCOS and vitamin D deficiency compared vitamin D supplementation with placebo. Parameters such as waist-to-hip ratio (WHR), body mass index (BMI), oral glucose tolerance test (OGTT), and lipid metabolism indices were assessed. After three months, the vitamin D group demonstrated significant improvements in insulin concentrations, BMI, WHR, triglycerides, low-density lipoprotein cholesterol (LDL-C), and total cholesterol compared to the control group (p

Fields of Study & Subjects

Ovarian function and disorders Diabetes Cardiovascular Risks and Lipoproteins Endometriosis Research and Treatment

Publication details

Journal / source
Journal of the Pakistan Medical Association
Volume
76
Issue
03
Pages
489–489
Publication date
1 March 2026
Language
EN